Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015
|
|
- Annabel Golden
- 5 years ago
- Views:
Transcription
1 Medication Management Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March
2 Medication Management Objectives: 1. Principles of psycho-pharmacology 2. Common mental health conditions 3. Frequent issues in general practice 4. Risks related to medication 5. Cases 2
3 Principles of psycho-pharmacology - Principle Diagnosis, Co-morbid conditions - Treatment options for the condition: Bio-Psycho-Social approach - Informed consent - Medication selection Evidence based, Treatment Guidelines Age, sex, body weight, special groups 3
4 Principles of psycho-pharmacology- cont. When are medication used? What is the optimal dose? What the maintenance dose? Monitoring of mental and physical state Regular risk assessment Failure to respond to treatment, Why? Discontinuation of medication 4
5 The phase of Treatment Subside acute symptoms Relieve symptoms Restore previous level of function (REHABILITATION) Maintain stabilization Prevent return of acute symptoms Continue Rx for the duration of the episode E.g. Depression 6/12 First Episode Psychosis 2 years Recurrent relapses- many yrs, lifelong Relapse prevention 5
6 Common mental health issues Mood disorders Anxiety disorders Psychotic disorders Drug and alcohol disorders Personality disorders 6
7 Cases and possible interventions: 1. Commencement of medication 2. Titration of medication 3. Change of medication 4. Combination of medications/ Poly-pharmacy 5. Interaction of medication 6. Interaction of medication and substances/ alcohol: 7. Non-adherence of medication 7
8 Commencement of medication Case 1: 45 year old professional, female, single, lives alone Diagnosis: severe OCD, no acute risks, affecting her work and social life, became unemployed due to ongoing symptoms and secondary depression Never treated with antidepressant medication, not willing to see a psychologist, but willing to see a psychiatrist Not happy to take antidepressants Group Discussion 8
9 Case 1, Management: Had initial assessment and provided treatment options. Fluctuated her insight, fear of medication side effects and questioning possible improvement. Took 3 months to convince her pharmacological treatment. Commence Paroxetine 10mg mane and titrate up to 20mg after few months. Tolerated side effects well, improved significantlymentally, socially, professionally. No relapses for the last 3 years. Take home message psycho-education ++++, provide options, engage, develop trust, support the patient to understand the nature of illness, titrate medication up slowly, monitor regularly 9
10 Titration of medication Case 2: 78 year old lady, lives with husband, previous psychiatric history +, no drug and alcohol history Diagnoses: Generalized Anxiety Disorder with secondary depression, Eating Disorder NOS, Cluster C Personality traits (dependent, avoidant, anxious) GP commenced Escitalopram 5mg mane few weeks ago, Zolpidem 10mg nocte 12 months ago Issues: extremely fearful of increasing the dose, slowly deteriorating for more than 2 years- physically, socially, psychologically, not safe at home, can not increase medication due to her fears Group Discussion 10
11 Case 2: Management: GP referred the patient to a private psych inpatient unit. Admitted to a private psychiatric unit, educated the patient and family, engage, assess regularly, titrated the dose of Escitalopram by 2.5mg increments up to 15mg at night, not developed any side effect, started reducing the dose of Zolpidem Incorporated CBT, regular day leave with the family and prepare for discharge Take home message- Psycho-education ++++, support the patient and family to understand the nature of illness, titrate slowly, monitor regularly Avoid long-term use of hypnotics/ Benzodiazepine Get specialist opinion early 11
12 Change of medication Case 3: 35 year old gentleman, single, stressed at work due to work load, on medical leave and subsequently lost his job. Diagnoses: Major Depressive Disorder, Cluster C personality traits Was on Mirtazapine 60mg nocte for few months, worsening depressive symptoms and suicidal ideation Mirtazapine was ceased abruptly and commenced Paroxetine 20mg mane Became extremely anxious and depressed, sleep disturbances, Emergency Dept, Crisis team involvement Group Discussion 12
13 Case 3: cont. Issues related to medication change: - Abrupt discontinuation of highest dose of Mirtazapine and commencement of Paroxetine - Possible short term use of Diazepam - Regular reviews Management: Regular MSEx, Reassurance, adding Diazepam. Later reduce and ceased diazepam Involvement of a clinical psychologist Take home message: educate the patient, involve family, wean of the medication, review the patient regularly, private admission +/-, involve Crisis Team 13
14 Interaction of medication and substances/ alcohol: Case 4: 68 year old businessman, lives with wife, adult children Diagnoses: Major Depressive Disorder, Alcohol Dependence, relationship difficulties, sexual dysfunction Issues: ongoing depressive symptoms for years, risk of suicide as father also committed suicide, Work long hours- 7 days a week Medication: Mirtazapine 90mg nocte, Venlafaxine XR 150mg mane, Diazepam 5-10mg PRN Group Discussion 14
15 Case 4, Management: Assessed regularly, educate patient and wife, treatment options explained (including Lithium Carbonate therapy as an adjunct) Counsel in relation to effects of alcohol ---- ceased alcohol use completely Regular phone discussions with the GP only one prescriber Cease Mirtazapine and diazepam Titrated up Venlafaxine XR 300mg mane Life style modifications: work (Mon-Fri), encourage to engage in his previous pleasure activities Significant improvement in all domains, no relapses Take home message: address alcohol and substance abuse, simplify medication regimen to minimize interaction, avoid poly-pharmacy, better communication bet therapists/ patient/ family, consider Lithium Carbonate 15
16 Non-adherence of medication Case 5: 30 year old, single man, lives alone, work 3-4 days a week, could not Diagnoses: Paranoid Schizophrenia, alcohol abuse Medication: Risperidone 3mg nocte, good response to medication when he takes them daily Issues: ongoing Persecutory delusions, alcohol abuse, poor adherence to medication, could not attend work regularly due to persecutory delusions, risk of harming others and self, risk of resistance to medication, emerging negative symptoms Group Discussion 16
17 Case 5, Plan of management: Psycho-education, Address alcohol abuse Engagement with the treatment plan, Introduce Webster/ Blister pack Commencement of Risperidone Consta (depot medication) fortnightly instead of oral Risperidone to improve medication adherence Take home message: Address non-adherence the medication, Treat co-morbid alcohol/ substance abuse, get specialist opinion in early phase of psychotic disorders to prevent negative symptoms, multiple relapses 17
18 Thank you. Dr Ajith Weeraman 18
Mood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationIntro to Concurrent Disorders
CSAM-SCAM Fundamentals Intro to Concurrent Disorders Presentation provided by Jennifer Brasch, MD, FRCPC Psychiatrist, Concurrent Disorders Program, St. Joseph s Healthcare There are all kinds of addicts,
More informationAiming for recovery for patients with severe or persistent depression a view from secondary care. Chrisvan Koen
Aiming for recovery for patients with severe or persistent depression a view from secondary care Chrisvan Koen Kent and Medway NHS and Social care Partnership trust Persistent depressive disorder F34 Persistent
More informationDepression: Assessment and Treatment For Older Adults
Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationOxleas CAMHS Dr Joanna Sales Clinical Director. Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis
Oxleas CAMHS Dr Joanna Sales Clinical Director Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis PREVALENCE At any one time, the estimated number of children and young
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationUnderstanding Psychiatry & Mental Illness
Understanding Psychiatry & Steve Ellen Mental Illness MB, BS. M.Med. MD. FRANZCP Head, Consultation, Liaison & Emergency Psychiatry, Alfred Health. Associate Professor, Monash Alfred Psychiatry Research
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationMENTAL HEALTH DISEASE CLASSIFICATIONS
MENTAL HEALTH DISEASE CLASSIFICATIONS DIAGNOSIS OF MENTAL DISORDERS DSM-IV-TR Published by APA ( 2000 ) Multiaxial system 5 categories called axes Facilitate holistic assessment for care Is a great resource
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationPSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust
PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationMANAGING PERSONALITY DISORDERS on Women s PICU Dr Paola Rossin
MANAGING PERSONALITY DISORDERS on Women s PICU 03.06.16 Dr Paola Rossin Easy! Don t admit patients with Personality Disorder (PD), it isn t the right treatment ( Nice guidelines National guidance on PICUs)
More informationPrescribing for people with a personality disorder. POMH-UK QIP 12b
Prescribing for people with a personality disorder POMH-UK QIP 12b Personality disorder Personality disorders are a heterogeneous group of conditions which vary greatly in their severity Characterised
More informationPrescribing medications for people with a personality disorder A service evaluation of a community mental health team
Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Dr Umama Khan, Consultant Psychiatrist Dr Venkatesh Ballagere, Specialist Registrar
More informationCASE 5 - Toy & Klamen CASE FILES: Psychiatry
CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The
More informationMedication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG
Medication management of anxiety & depression Dr Katie impson GP Mental health lead East Berks CCG NICE guidelines for Anxiety tepped Care RIs and NRIs in Anxiety disorders RI ertraline Citalopram Fluoxetine
More informationCharles B. Nemeroff, M.D., Ph.D.
CASE STUDY 1 Charles B. Nemeroff, M.D., Ph.D. Leonard M. Miller Professor and Chairman Department of Psychiatry and Behavioral Sciences Director, Center on Aging University of Miami Miller School of Medicine
More informationRelationship Between Mental Health Problems and Challenging Behaviour in People with Intellectual Disabilities
Relationship Between Mental Health Problems and Challenging Behaviour in People with Intellectual Disabilities Dr Vikram Palanisamy MD Psych, Dip in Clinical Psych, MRC Psych CCT in Intellectual Disability
More informationSuicide, Para suicide and Risk Assessment
Suicide, Para suicide and Risk Assessment LPT Gondar Mental Health Group www.le.ac.uk Objectives: Definition of suicide, Para suicide/dsh Changing trends of methods used Epidemiology Clinical Variables
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationDepression in adults: treatment and management
1 2 3 4 Depression in adults: treatment and management 5 6 7 8 Appendix V3: recommendations that have been deleted of changed from 2009 guideline Depression in adults: Appendix V3 1 of 22 1 Recommendations
More informationWhat is Schizophrenia?
What is Schizophrenia? What is schizophrenia? Schizophrenia is a mental illness which affects one person in every hundred. Schizophrenia interferes with the mental functioning of a person and, in the long
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationReview: Psychosocial assessment and theories of development from N141 and Psych 101
Unit III Theory and Practice of Psychiatric Nursing REQUIRED READINGS AND ACTIVITIES Related Activities Assignments Review: Psychosocial assessment and theories of development from N141 and Psych 101 Anxiety,
More informationMERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES
MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines
More informationMalaysian Healthy Ageing Society
{ Organised by: Co-Sponsored: Malaysian Healthy Ageing Society Promoting Healthy Ageing in Depressed Elderly Patients Ist World Congress On Healthy Ageing Evolution: Holistic Ageing in an Age of change
More informationPharmacological Treatment of Anxiety & Depressive Disorders
Pharmacological Treatment of Anxiety & Depressive Disorders Dr Gary Jackson (MB BCh FRCPsych) Consultant Psychiatrist The Priory Hospital Chelmsford Wellesley Hospital Southend-on-Sea Medical Secretary:
More informationAmerican Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline
American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline I. Geriatric Psychiatry Patient Care and Procedural Skills Core Competencies A. Geriatric psychiatrists shall
More informationNavigating Student Mental Health Issues
Navigating Student Mental Health Issues Brian D. Saunders, MD, FACS Director of Undergraduate Surgical Education Penn State College of Medicine Trouble Shooting Your Clerkship 103 April 22, 2013 Orlando,
More informationKari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD
IN PRIMARY CARE June 17, 2010 Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington Defining and assessing Approach for doing differential diagnosis of Best
More informationPOLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 2012 PSYCHOPHARMACOLOGY SERIES. Guna Kanniah Waikato Hospital
POLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 212 PSYCHOPHARMACOLOGY SERIES Guna Kanniah Waikato Hospital POLYPHARMACY FIVE REASONS FOR POLYPHARMACY 1. To treat a concomitant disorder 2. To treat an
More informationSuicide Spectrum Assessment and Interventions. Welcome to RoseEd Academy. Disclaimer
RoseEd Module 7 Suicide Spectrum Assessment and Interventions Suicide Spectrum Assessment and Interventions J. Scott Nelson MA NCC LPC CRADC Staff Education Coordinator Welcome to RoseEd Academy Disclaimer
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationMental Health and Sexual Health. John Green CNWL NHS Trust, St Mary s Hospital London, Imperial College London
Mental Health and Sexual Health John Green CNWL NHS Trust, St Mary s Hospital London, Imperial College London The most common mental health problems are anxiety and depression Most people will experience
More informationThe Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability
The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide EATING DISORDER
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH National Institute of Mental Health) and the National Eating Disorders Association
More informationDIAGNOSTIC CRITERIA (ICD 10)
DEPRESSION Depression is a major public health problem around the world Affects 1:5 older people living in the community Affects 2:5 older people living in care homes Various treatment options available,
More informationChapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%
Chapter 12 Schizophrenia and Schizophrenia Spectrum Disorders Epidemiology Lifetime prevalence of schizophrenia is 1% No difference related to 2 Comorbidity Substance abuse disorders Anxiety, depression,
More informationHow to Manage Anxiety
How to Manage Anxiety Dr Tony Fernando Psychological Medicine University of Auckland Auckland District Health Board www.insomniaspecialist.co.nz www.calm.auckland.ac.nz Topics How to diagnose How to manage
More informationDEPRESSION Depression is a major public health problem around the world Affects 1:5 older people living in the community Affects 2:5 older people living in care homes Various treatment options available,
More informationBorderline personality disorder: what role for medication?
Borderline personality disorder: what role for medication? Mike Crawford Imperial College London CNWL NHS Foundation Trust m.crawford@imperial.ac.uk Licensed medication for PD Jane, 34, moderately severe
More informationDocument Title Pharmacological Management of Generalised Anxiety Disorder
Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)
More informationManagement of a HIV-infected patient with a psychiatric disorder
Management of a HIV-infected patient with a psychiatric disorder Maria Ferrara, Modena, Italia Guida Da Ponte, Lisboa, Portugal Jordi Blanch, Barcelona Main complaint Mr M is a 30-year-old HIV+ man In
More informationANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN
UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL
More informationProfessor Tony Holland, Department of Psychiatry, University of Cambridge
INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with
More informationDisclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression
Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression Disclosures The speakers have no disclosures. Lisa Ochoa-Frongia, MD Christina Mangurian, MD, MAS L. Elizabeth
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationManaging Common Mental Health Problems
Managing Common Mental Health Problems Dr John S Parker MBBCh; FCPsych(SA) Dept of Psychiatry and Mental Health, Faculty of Health Sciences, UCT. Lentegeur Psychiatric Hospital SAMA Conference 2016 Universal
More informationHealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy
HealthyPlace s Introductory Guide to Bipolar Disorder By Natasha Tracy 1 Index Introduction Chapter One Bipolar Disorder Basics Chapter Two Bipolar Disorder Diagnosis Chapter Three Treatment of Bipolar
More informationPractice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association
Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association Our clinical advisor adds updated advice on electroconvulsive therapy, transcranial magnetic
More informationDrug History Zopiclone 3.75mg ON PRN (Review Overdue) Clozapine 50mg OM and 75mg ON (Prescribed by the mental health team)
Doctor s Instructions Patient: Pradeep Singh Age: 28 years old Last Consultations Dr Fitzpatrick 1 week ago Admin Note: Script request for zopiclone declined as medication review overdue, advised to make
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service
1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient
More informationLIAISON PSYCHIATRY FOR OLDER PEOPLE
LIAISON PSYCHIATRY FOR OLDER PEOPLE Fiona Thompson Consultant Psychiatrist Addenbrookes Hospital US LP mid 18 th Century UK after WW2 Developmental History 1948 WHO defined health as a state of complete
More informationVO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT)
VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT) Diagnostic Guidelines: Introduction: Electroconvulsive Therapy has been in continuous use for more than 60 years. The clinical literature
More informationIDDT Fidelity Action Planning Guidelines
1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition
More informationPerinatal Mental Health
Perinatal Mental Health Dr. Tara Lawn Consultant Psychiatrist Sasha Singh Modern Matron Dr Sarah Jones ST5 Perinatal Mental Health at E9 City & Hackney Centre for Mental Health What is Perinatal Psychiatry?
More informationKaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System
Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System 12-Month Customer Report, January to December, 2007 We exist to help
More informationThe In-betweeners: What to do with problem gamblers with mental health problems. Neil Smith National Problem Gambling Clinic CNWL NHS Trust
The In-betweeners: What to do with problem gamblers with mental health problems Neil Smith National Problem Gambling Clinic CNWL NHS Trust Dual Diagnosis Addiction Mental Illness Mental health problems
More informationAffective Disorders.
Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders
More informationSECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario
SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with
More informationDepression Disease Navigation
Depression Disease Navigation The depression disease navigation program is designed to reach out to members who have been diagnosed with major depression disorder. This is accomplished by promoting treatment
More informationMargaret Oates Maternal Mental Health and Liaison Mental Health
Margaret Oates 26.02.16 Maternal Mental Health and Liaison Mental Health Most acute hospitals have Maternity Units Most maternity units do not have specific specialised perinatal mental health services
More informationYouth Mental Health Awareness JAMIE KURIGER RUTH LIEBOLD
Youth Mental Health Awareness JAMIE KURIGER RUTH LIEBOLD What are mental health challenges and mental disorders? Mental Disorder or Mental Illness Diagnosable illness that affects a person s thinking,
More informationWorking with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers
Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers Tuesday, February 23, 2016 2pm Eastern Delbert Robinson, M.D. Professor of Psychiatry and Molecular Medicine
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationAdult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160
Adult Mental Health Services Comparison Create and maintain a document in an easily accessible location on such health carrier's Internet web site that (i) (ii) compares each aspect of such clinical review
More informationDepression: selective serotonin reuptake inhibitors
Depression: selective serotonin reuptake inhibitors Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. citalopram and fluoxetine
More informationAntidepressants for treatment of depression.
JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic
More informationMood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland
Mood Disorders Workshop 2010 Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Goals To learn about the clinical presentation of mood
More informationAchieve Remission in Adult Patients With Non-Psychotic Major Depressive Disorder: Algorithm
Achieve Remission in Adult Patients With Non-Psychotic Major Depressive Disorder: Algorithm Initiate antidepressant at minimally-effective dose to optimize tolerability. Refer for cognitive-behavioral
More informationMental Health Series for Perinatal Prescribers. Severe postpartum syndromes
Mental Health Series for Perinatal Prescribers Severe postpartum syndromes 2 Maternal Filicides Acutely psychotic - 24% Depression Altruistic - 56% to relieve suffering associated with suicide 80% due
More informationZero Suicide Pathway. Suicide Prevention Strategy The Gold Coast Mental Health and Specialist Service
2016-2018 The Gold Coast Mental Health and Specialist Service Suicide Prevention Strategy 2016-2018 Zero Suicide Pathway Dr Kathryn Turner Clinical Director GCMHSS Matt Welch CNC PM Conf July 2017 V1 template
More information4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue
Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Disclosures Financial relationships with commercial interests Douglas R. Robbins, M.D. Maine Medical Center Tufts University
More informationBenzodiazepines: risks, benefits or dependence
Benzodiazepines: risks, benefits or dependence A re-evaluation Council Report CR 59 January 1997 Royal College of Psychiatrists, London Due for review: January 2002 1 Contents A College Statement 3 Benefits
More informationFor: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013
For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please
More informationPsychotropic Medication
FOM 802-1 1 of 10 OVERVIEW The use of psychotropic medication as part of a child s comprehensive mental health treatment plan may be beneficial and should include consideration of all alternative interventions.
More informationGuidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in
More informationTreatment Algorithm Treatment Algorithm
Treatment Algorithm Treatment Algorithm Primary Care Toolkit September 2015 Page 2 Adult (>18 years) Depression Flow Chart (Generic) Two Question Screen: PHQ-2 Annually, new adult patients, and when suspect
More informationDepression in children: identification and management of depression in children and young people in primary, community and secondary care
Depression in children: identification and management of depression in children and young people in primary, community and secondary care NICE guideline First consultation, November 2004 If you wish to
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationAnxiety Disorders: First aid and when to refer on
Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationPSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE
PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE Introduction and General Principles April 2017 Adapted for New Mexico from with permission from the Texas Department
More informationManaging Behavioural Problems in Patients with Learning Disabilities
Managing Behavioural Problems in Patients with Learning Disabilities Some people with a learning disability display behaviour that challenges. Although such behaviour is a challenge to services, family
More informationI m in Crisis. Now what?
Tammy M. White, LPCC I m in Crisis. Now what? Crisis: a time of intense difficulty, trouble, or danger. Welcome Tammy M. White, LPCC School-Community Liaison & Therapist Health Officer Mental Health and
More informationCharles B. Nemeroff, M.D., Ph.D.
CASE STUDY 2 Charles B. Nemeroff, M.D., Ph.D. Leonard M. Miller Professor and Chairman Department of Psychiatry and Behavioral Sciences Director, Center on Aging University of Miami Miller School of Medicine
More informationJennifer M. Lytle, M.D., M.P.H. Clinical Trials of the Rockies 3955 E. Exposition Avenue, Suite 100 Denver, CO Tel.
CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com EDUCATION: Jennifer M. Lytle, M.D., M.P.H.
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More information